Although these significant differences in VSIR expression were evident based on cytogenetics in AML, molecular mutations including DNMT3A, 11q23 amplification, FLT3, NPM1, and TP53 did not correlate significantly with VSIR RNA levels (Supplemental Figure 1E). This evidence concerns the gene TP53 and acute myeloid leukemia.